Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Drugs in R&D|September 11, 2004
Bioequivalence of two recombinant interferon alpha-2b liquid formulations in healthy male volunteersIdrian Garcia-Garcia, Carlos Alberto Gonzalez-Delgado, Carmen Valenzuela-Silva, et al.
Cardiovascular Research|December 16, 2014
Marine n-3 PUFAs modulate IKs gating, channel expression, and location in membrane microdomainsCristina Moreno, Alicia de la Cruz, Anna Oliveras, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 24, 2014
Functional assembly of Kv7.1/Kv7.5 channels with emerging properties on vascular muscle physiologyAnna Oliveras, Meritxell Roura-Ferrer, Laura Solé, et al.
Pharmacological Research|February 5, 2023
Sigma-1 receptor modulation fine-tunes KV1.5 channels and impacts pulmonary vascular functionAlba Vera-Zambrano, Maria Baena-Nuevo, Susanne Rinné, et al.
Alzheimer'S Research & Therapy|December 14, 2023
NeuroEPO plus (NeuralCIM®) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trialSaily Sosa, Giosmany Bringas, Nelky Urrutia, et al.
Revista Espanola De Cardiologia (English Ed.)|May 26, 2018
Start-up of a Cardiology Day Hospital: Activity, Quality Care and Cost-effectiveness Analysis of the First Year of OperationMaría Gallego-Delgado, Eduardo Villacorta, M Carmen Valenzuela-Vicente, et al.
Plos Pathogens|November 1, 2023
Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individualsSana Eybpoosh, Alireza Biglari, Rahim Sorouri, et al.
BMC Cancer|May 15, 2009
Safety and preliminary efficacy data of a novel casein kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignanciesAna M Solares, Agueda Santana, Idania Baladrón, et al.
Immunity & Ageing : I & A|December 9, 2020
An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patientsDanay Saavedra, Ana Laura Añé-Kourí, Naivy Sánchez, et al.
Plos One|May 11, 2011
Irvalec inserts into the plasma membrane causing rapid loss of integrity and necrotic cell death in tumor cellsJosé M Molina-Guijarro, Álvaro Macías, Carolina García, et al.
Pageof 12